我国一九八五年版药典明确规定,胰酶“每1g含胰蛋白酶不得少于600单位,胰淀粉酶不得少于7000单位,胰脂肪酶不得少于4000单位”。但国内大多数厂家生产的胰酶只注意到胰蛋白酶,测定方法是已经淘汰了的转化酪蛋白的方法(我国一九七七年版药典的胰酶标准早已通知停用),未测定胰淀粉酶和胰脂肪酶。按我国药品管理法规定“禁止生产,销售劣药,有下列情形之一的药品为劣药:一、药品成份 China’s 1985 edition of the Pharmacopoeia clearly stipulates that trypsin “per 1g of trypsin not less than 600 units, pancreatic amylase not less than 7000 units, pancreatic lipase not less than 4000 units.” However, trypsin is only noticed in trypsin produced by most domestic manufacturers. The method of determination is already a method of converting casein (China’s 1977 Pharmacopoeia pancreatin standard has already been notified to disable), pancreatic amylase And pancreatic lipase. According to China’s Drug Administration Law "prohibit the production and sale of substandard drugs, one of the following cases of drugs as inferior drugs: First, the pharmaceutical ingredients